Last reviewed · How we verify
Thromboembolism due to Prosthetic Heart Valves
Approved treatments
- Coumadin · Generic (originally Wisconsin Alumni Research Foundation)
Inhibits vitamin K epoxide reductase, blocking the synthesis of vitamin K-dependent clotting factors (II, VII, IX, X) to prevent thrombosis.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Thromboembolism due to Prosthetic Heart Valves patent landscape — cliff calendar, originator estates, attackable patents
- Thromboembolism due to Prosthetic Heart Valves treatment landscape brief
- Thromboembolism due to Prosthetic Heart Valves treatment updates RSS
Frequently asked questions about Thromboembolism due to Prosthetic Heart Valves
What drugs treat Thromboembolism due to Prosthetic Heart Valves?
Tracked treatments include Coumadin.
What is the treatment for Thromboembolism due to Prosthetic Heart Valves?
Standard treatment for Thromboembolism due to Prosthetic Heart Valves includes Coumadin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Thromboembolism due to Prosthetic Heart Valves patent cliff · Thromboembolism due to Prosthetic Heart Valves CI report
- Treatment: Coumadin · Generic (originally Wisconsin Alumni Research Foundation)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing